Renshaw PF - Search Results

1

Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine.

Sonawalla SB, Renshaw PF, Moore CM, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M. Sonawalla SB, et al. Among authors: renshaw pf. Am J Psychiatry. 1999 Oct;156(10):1638-40. doi: 10.1176/ajp.156.10.1638. Am J Psychiatry. 1999. PMID: 10518178 Clinical Trial.

2

Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration.

Renshaw PF, Guimaraes AR, Fava M, Rosenbaum JF, Pearlman JD, Flood JG, Puopolo PR, Clancy K, Gonzalez RG. Renshaw PF, et al. Am J Psychiatry. 1992 Nov;149(11):1592-4. doi: 10.1176/ajp.149.11.1592. Am J Psychiatry. 1992. PMID: 1415832

3

Measurement of human brain lithium in vivo by MR spectroscopy.

González RG, Guimaraes AR, Sachs GS, Rosenbaum JF, Garwood M, Renshaw PF. González RG, et al. Among authors: renshaw pf. AJNR Am J Neuroradiol. 1993 Sep-Oct;14(5):1027-37. AJNR Am J Neuroradiol. 1993. PMID: 8237676 Free PMC article.

4

Variability of brain lithium levels during maintenance treatment: a magnetic resonance spectroscopy study.

Sachs GS, Renshaw PF, Lafer B, Stoll AL, Guimarães AR, Rosenbaum JF, Gonzalez RG. Sachs GS, et al. Among authors: renshaw pf. Biol Psychiatry. 1995 Oct 1;38(7):422-8. doi: 10.1016/0006-3223(94)00324-v. Biol Psychiatry. 1995. PMID: 8672602

5

Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients.

Stoll AL, Sachs GS, Cohen BM, Lafer B, Christensen JD, Renshaw PF. Stoll AL, et al. Among authors: renshaw pf. Biol Psychiatry. 1996 Sep 1;40(5):382-8. doi: 10.1016/0006-3223(95)00423-8. Biol Psychiatry. 1996. PMID: 8874839 Clinical Trial.

6

A technique for detecting GABA in the human brain with PRESS localization and optimized refocusing spectral editing radiofrequency pulses.

Keltner JR, Wald LL, Christensen JD, Maas LC, Moore CM, Cohen BM, Renshaw PF. Keltner JR, et al. Among authors: renshaw pf. Magn Reson Med. 1996 Sep;36(3):458-61. doi: 10.1002/mrm.1910360319. Magn Reson Med. 1996. PMID: 8875418

7

Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study.

Moore CM, Christensen JD, Lafer B, Fava M, Renshaw PF. Moore CM, et al. Among authors: renshaw pf. Am J Psychiatry. 1997 Jan;154(1):116-8. doi: 10.1176/ajp.154.1.116. Am J Psychiatry. 1997. PMID: 8988971

8

Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study.

Renshaw PF, Lafer B, Babb SM, Fava M, Stoll AL, Christensen JD, Moore CM, Yurgelun-Todd DA, Bonello CM, Pillay SS, Rothschild AJ, Nierenberg AA, Rosenbaum JF, Cohen BM. Renshaw PF, et al. Biol Psychiatry. 1997 Apr 15;41(8):837-43. doi: 10.1016/S0006-3223(96)00256-9. Biol Psychiatry. 1997. PMID: 9099409 Clinical Trial.

9

A quantitative magnetic resonance imaging study of cerebral and cerebellar gray matter volume in primary unipolar major depression: relationship to treatment response and clinical severity.

Pillay SS, Yurgelun-Todd DA, Bonello CM, Lafer B, Fava M, Renshaw PF. Pillay SS, et al. Among authors: renshaw pf. Biol Psychiatry. 1997 Jul 15;42(2):79-84. doi: 10.1016/S0006-3223(96)00335-6. Biol Psychiatry. 1997. PMID: 9209723

10

Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist.

Satlin A, Bodick N, Offen WW, Renshaw PF. Satlin A, et al. Among authors: renshaw pf. Am J Psychiatry. 1997 Oct;154(10):1459-61. doi: 10.1176/ajp.154.10.1459. Am J Psychiatry. 1997. PMID: 9326834 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

455 results

Search Page